These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35974381)

  • 1. Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis.
    Ge C; Du K; Luo M; Shen K; Zhou Y; Guo K; Liu Y; Yin C; Li Y; Li G; Chen X
    Exp Hematol Oncol; 2022 Aug; 11(1):46. PubMed ID: 35974381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a systematic review and meta-analysis.
    Sharifi Aliabadi L; Azari M; Taherian MR; Barkhordar M; Abbas SAM; Azari M; Ahmadvand M; Salehi Z; Rouzbahani S; Vaezi M
    Virol J; 2024 May; 21(1):103. PubMed ID: 38702752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to vaccination against SARS-CoV-2 in hematopoietic stem cell transplantation and CAR T-cell therapy recipients.
    Wu X; Wang L; Shen L; He L; Tang K
    J Hematol Oncol; 2022 Jun; 15(1):81. PubMed ID: 35710431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response-a prospective, single-arm study.
    Barkhordar M; Chahardouli B; Biglari A; Ahmadvand M; Bahri T; Alaeddini F; Sharifi Aliabadi L; Noorani SS; Bagheri Amiri F; Biglari M; Shemshadi MR; Ghavamzadeh A; Vaezi M
    Front Immunol; 2023; 14():1169666. PubMed ID: 37153556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COVID-19 monoclonal antibodies on outcomes of COVID-19 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients.
    Hahn EH; Li H; Sauter CS; Mossad SB
    Transpl Infect Dis; 2024 Aug; 26(4):e14322. PubMed ID: 38937864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy.
    Infante MS; Nemirovsky D; Devlin S; DeWolf S; Tamari R; Dahi PB; Lee YJ; Chung DJ; Politikos I; Barker J; Giralt SA; Babady NE; Ramanathan L; Papanicolaou GA; Seo S; Kamboj M; Perales MA; Shah GL
    Transplant Cell Ther; 2024 Jan; 30(1):116.e1-116.e12. PubMed ID: 37806446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination.
    Piñana JL; Martino R; Vazquez L; López-Corral L; Pérez A; Chorão P; Avendaño-Pita A; Pascual MJ; Sánchez-Salinas A; Sanz-Linares G; Olave MT; Arroyo I; Tormo M; Villalon L; Conesa-Garcia V; Gago B; Terol MJ; Villalba M; Garcia-Gutierrez V; Cabero A; Hernández-Rivas JÁ; Ferrer E; García-Cadenas I; Teruel A; Navarro D; Cedillo Á; Sureda A; Solano C;
    Bone Marrow Transplant; 2023 May; 58(5):567-580. PubMed ID: 36854892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.
    Lee ARYB; Wong SY; Chai LYA; Lee SC; Lee MX; Muthiah MD; Tay SH; Teo CB; Tan BKJ; Chan YH; Sundar R; Soon YY
    BMJ; 2022 Mar; 376():e068632. PubMed ID: 35236664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 in hematopoietic stem-cell transplant recipients: A systematic review and meta-analysis of clinical characteristics and outcomes.
    Randi BA; Higashino HR; Silva VPD; Xavier EM; Rocha V; Costa SF
    Rev Med Virol; 2023 Nov; 33(6):e2483. PubMed ID: 37794598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Safety and Immunogenicity of a Recombinant Receptor-Binding Domain (RBD)-Tetanus Toxoid (TT) Conjugated SARS-CoV-2 Vaccine (PastoCovac) in Recipients of Autologous Hematopoietic Stem Cell Transplantation Compared to the Healthy Controls; A Prospective, Open-Label Clinical Trial.
    Barkhordar M; Ahmadvand M; Sharifi Aliabadi L; Noorani SS; Bagheri Amiri F; Janbabai G; Sorouri R; Asadi Milani M; Vaezi M
    Vaccines (Basel); 2023 Jan; 11(1):. PubMed ID: 36679963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.
    Shahzad M; Chaudhary SG; Zafar MU; Hassan MA; Hussain A; Ali F; Anwar I; Ahmed M; Ahmed N; Khurana S; Rauf MA; Anwar F; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
    Transpl Infect Dis; 2022 Apr; 24(2):e13792. PubMed ID: 35030267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Seropositivity after Live Attenuated Vaccine in Adult Patients Receiving Hematopoietic Stem Cell Transplantation.
    Aoki T; Kamimura T; Yoshida S; Mori Y; Kadowaki M; Kohno K; Ishihara D; Urata S; Sugio T; Kamezaki K; Kato K; Ito Y; Eto T; Akashi K; Miyamoto T
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1576-1585. PubMed ID: 30959161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients-A Retrospective Single-Center Analysis.
    Nikoloudis A; Neumann IJ; Buxhofer-Ausch V; Machherndl-Spandl S; Binder M; Kaynak E; Milanov R; Nocker S; Stiefel O; Strassl I; Wipplinger D; Moyses M; Kerschner H; Apfalter P; Girschikofsky M; Petzer A; Weltermann A; Clausen J
    Vaccines (Basel); 2023 Sep; 11(10):. PubMed ID: 37896938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of early vaccination with live attenuated measles vaccine for hematopoietic stem cell transplant recipients and solid organ transplant recipients.
    Groeneweg L; Loeffen YGT; Versluys AB; Wolfs TFW
    Vaccine; 2021 Jun; 39(25):3338-3345. PubMed ID: 33992440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology.
    Khawaja F; Papanicolaou G; Dadwal S; Pergam SA; Wingard JR; Boghdadly ZE; Abidi MZ; Waghmare A; Shahid Z; Michaels L; Hill JA; Kamboj M; Boeckh M; Auletta JJ; Chemaly RF
    Transplant Cell Ther; 2023 Jan; 29(1):10-18. PubMed ID: 36273782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 vaccine response in CAR T-cell therapy recipients: A systematic review and preliminary observations.
    Abid MA; Abid MB
    Hematol Oncol; 2022 Apr; 40(2):287-291. PubMed ID: 34911142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy.
    Chen W; Ma Y; Shen Z; Chen H; Ma R; Yan D; Shi M; Wang X; Song X; Sun C; Cao J; Cheng H; Zhu F; Sun H; Li D; Li Z; Zheng J; Xu K; Sang W
    Front Immunol; 2021; 12():755549. PubMed ID: 34777367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis.
    Verleye A; Wijtvliet V; Abrams S; Hellemans R; Bougrea R; Massart A; Pipeleers L; Wissing KM; Ariën KK; De Winter BY; Van Damme P; Abramowicz D; Ledeganck KJ
    Nephrol Dial Transplant; 2022 Jul; 37(8):1566-1575. PubMed ID: 35544087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients.
    Conrad A; Boccard M; Valour F; Alcazer V; Tovar Sanchez AT; Chidiac C; Laurent F; Vanhems P; Salles G; Brengel-Pesce K; Meunier B; Trouillet-Assant S; Ader F;
    BMJ Open; 2019 Feb; 9(2):e026093. PubMed ID: 30772864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future.
    Hall VG; Teh BW
    J Infect Dis; 2023 Aug; 228(Suppl 1):S55-S69. PubMed ID: 37539765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.